Key Insights

Highlights

Treatment Research

1 treatments under study, led by Setmelanotide

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06760546Phase 3Recruiting

A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)

Showing all 1 trials

Research Network

Common Treatments

  • Setmelanotide1

Active Sponsors

  • Rhythm Pharmaceuticals, Inc.1

Top Investigators

Related Conditions

  • Multiple Pituitary Hormone Deficiency Genetic Form1
  • Septooptic Dysplasia1
  • Pituitary Stalk Interruption Syndrome1
  • Hypothalamic Obesity1
  • Optic Nerve Hypoplasia1

Activity Timeline